Charles D. Scales, Jr., MD, FACS, MS

Duke University School of Medicine

Charles D. Scales, Jr., MD MSHS is Associate Professor of Surgery and Director of the Duke Surgical Center for Outcomes Research Equity in Surgery at Duke University School of Medicine. He completed medical school and residency training in urology at Duke University Medical Center. After residency, Dr. Scales completed the Robert Wood Johnson Foundation Clinical Scholars Program at UCLA, where he received advanced training in health services research, health policy, and quality of care.

Dr. Scales has a strong interest in education, having previously served on the ACGME Review Committee for Urology and as a member of the ACGME Board of Directors. He currently leads a course in quality improvement and data analytics in the Masters of Management in Clinical Informatics program at the Duke University School of Medicine.

From the research perspective, Dr. Scales has a longstanding interest in the epidemiology of and patient care for urinary stone disease. Recent studies have redefined the burden of urinary stone disease in the United States, compared the effectiveness of dominant stone removal technologies, and identified new opportunities for improving patient-centered and policy-relevant outcomes, such as unplanned care after procedural interventions. His research and perspective on urinary stone disease has been highlighted in U.S. News & World Report, Reuters, NPR, and the Wall Street Journal, among other media outlets.

As a result of these investigations, he has an appointment at the Duke Clinical Research Institute where he leads a diverse health services and clinical research program. He has received research support from the National Institute of Aging, the American Geriatrics Society, and philanthropic funding, among other sources. Currently, Dr. Scales is the Principal Investigator for the Scientific Data and Research Center for the NIDDK Urinary Stone Disease Research Network (www.usdrn.org) (U01).

Disclosure information not submitted.

Presentation(s):

• Panel Discussion: Stent Associated Symptoms after Ureteroscopy: Insights from the USDRN STENTS Study

  Saturday, May 14, 2022
  3:25 PM – 3:55 PM

• 039IC - Optimizing Surgical Outcomes in Older Adults

  Saturday, May 14, 2022
  1:30 PM – 3:30 PM

• What Outcomes Should We Track?

  Sunday, May 15, 2022
  3:40 PM – 4:45 PM

• PD50: Stone Disease: Epidemiology & Evaluation II

  Sunday, May 15, 2022
  3:30 PM – 5:30 PM

• PD50-11: The Patient Voice: Experiences with Ureteral Stent Removal – A Urinary Stone Disease Research Network (USDRN) Study

  Sunday, May 15, 2022
  5:10 PM – 5:20 PM